Fundraising FoxCambridge Capital Group — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
iFASTifastdiagnostics.cominMay 2026✓ verified
iFAST Diagnostics develops rapid antimicrobial susceptibility testing (AST) technology that delivers susceptibility test results in under 3 hours, significantly faster than the standard 40-hour process.
BiotechHealthtechMedical DevicesWhiteley, GB
Co-investorsMeridian Health VenturesInnovate UKRaw VenturesFuture Planet CapitalUK Innovation & Science Seed Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.